Involvement of TRPC6/NFAT axis and mitochondrial quality control in the protective effect of aerobic exercise against doxorubicin-induced cardiomyopathy

Doxorubicin (DOX), a common chemotherapeutic agent, leads to irreversible anthracycline-induced cardiomyopathy (AIC). Impaired mitochondrial quality control serves as a central pathogenic driver of AIC. Moreover, DOX provokes sustained overactivation of the TRPC6/NFAT cascade, generating self-amplifying excitation-transcription feedback in injured cardiomyocytes. Despite the well-documented cardioprotective potential of aerobic exercise, the causal interplay between TRPC6/NFAT signaling and mitochondrial homeostasis underlying this protection remains unclear. Male C57BL/6 J mice were randomly assigned to five groups with bidirectional pharmacological manipulation of TRPC6/NFAT activity: control, DOX, exercise + DOX, exercise + DOX + TRPC6 agonist hyperforin, and DOX + TRPC6 antagonist larixyl acetate. Aerobic exercise suppressed TRPC6/NFAT3 overactivation. This inhibition further normalized mitochondrial quality control by enhancing mitochondrial biogenesis, limiting excessive mitochondrial fission and suppressing excessive PINK1/Parkin-mediated mitophagy signaling. The improvement in mitochondrial homeostasis was accompanied by attenuated DOX-induced myocardial injury, hypertrophy, and interstitial fibrosis. Echocardiography revealed restored systolic function with elevated left ventricular ejection fraction (LVEF) and fractional shortening (LVFS). Treadmill testing further revealed recovered heart rate recovery (HRR), along with a longer exhaustive running distance and exercise duration. Notably, larixyl acetate recapitulated all exercise-conferred cardiac benefits, whereas hyperforin-mediated TRPC6/NFAT activation completely abrogated exercise-induced protection. In summary, aerobic exercise alleviates DOX-induced cardiomyopathy by disrupting the TRPC6/NFAT3 positive-feedback loop to restore mitochondrial quality control. This cascade of effects mitigates pathological myocardial remodeling, rescues left ventricular systolic performance, and increases systemic exercise tolerance, providing experimental evidence supporting exercise rehabilitation for patients with AIC.

Authors

Institutions

Publication Details

Journal
Cell Biology and Toxicology
Published
2026-11-16
DOI
https://doi.org/10.1007/s10565-026-10349-y
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Involvement of TRPC6/NFAT axis and mitochondrial quality control in the protective effect of aerobic exercise against doxorubicin-induced cardiomyopathy

Long‐Xin Gui, Hai-Xia Jiao, Rui-Xing Wang, Zhijuan Wu et al.
2 links
Cell Biology and Toxicology
Chemotherapy-induced cardiotoxicity and mitigation
article

Involvement of TRPC6/NFAT axis and mitochondrial quality control in the protective effect of aerobic exercise against doxorubicin-induced cardiomyopathy

Long‐Xin Gui, Hai-Xia Jiao, Rui-Xing Wang, Zhijuan Wu, Rui‐Lan He, Minxia Wu, Wenjing Yi, Gao Yi-qian, Junwei Zhang, Huan-Huan Zhang, Bin Zheng, Jian-Feng Jiang, Mo-Jun Lin, Meng-Ge Yao
article en

Abstract

Doxorubicin (DOX), a common chemotherapeutic agent, leads to irreversible anthracycline-induced cardiomyopathy (AIC). Impaired mitochondrial quality control serves as a central pathogenic driver of AIC. Moreover, DOX provokes sustained overactivation of the TRPC6/NFAT cascade, generating self-amplifying excitation-transcription feedback in injured cardiomyocytes. Despite the well-documented cardioprotective potential of aerobic exercise, the causal interplay between TRPC6/NFAT signaling and mitochondrial homeostasis underlying this protection remains unclear. Male C57BL/6 J mice were randomly assigned to five groups with bidirectional pharmacological manipulation of TRPC6/NFAT activity: control, DOX, exercise + DOX, exercise + DOX + TRPC6 agonist hyperforin, and DOX + TRPC6 antagonist larixyl acetate. Aerobic exercise suppressed TRPC6/NFAT3 overactivation. This inhibition further normalized mitochondrial quality control by enhancing mitochondrial biogenesis, limiting excessive mitochondrial fission and suppressing excessive PINK1/Parkin-mediated mitophagy signaling. The improvement in mitochondrial homeostasis was accompanied by attenuated DOX-induced myocardial injury, hypertrophy, and interstitial fibrosis. Echocardiography revealed restored systolic function with elevated left ventricular ejection fraction (LVEF) and fractional shortening (LVFS). Treadmill testing further revealed recovered heart rate recovery (HRR), along with a longer exhaustive running distance and exercise duration. Notably, larixyl acetate recapitulated all exercise-conferred cardiac benefits, whereas hyperforin-mediated TRPC6/NFAT activation completely abrogated exercise-induced protection. In summary, aerobic exercise alleviates DOX-induced cardiomyopathy by disrupting the TRPC6/NFAT3 positive-feedback loop to restore mitochondrial quality control. This cascade of effects mitigates pathological myocardial remodeling, rescues left ventricular systolic performance, and increases systemic exercise tolerance, providing experimental evidence supporting exercise rehabilitation for patients with AIC.

Cell Biology and Toxicology
Fujian Medical University (CN), Union Hospital (CN)
National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Fujian Medical University
Good health and well-being
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon